Our R&D group runs concurrent programmes — discovery-stage screening, process R&D for validated molecules, and green-chemistry optimisation. Every route goes through a green-chemistry review before we commit to scale-up.
Timelines vary by molecule and scope; the shape below applies to every engagement.
Discovery, process, or green-chemistry — clear success criteria.
Structured literature and patent-landscape review.
DoE-driven experimentation with in-line analytical support.
Assess safety, throughput, and cost before committing to pilot.
Client-facing report with data package, IP position, and next-step plan.
Independent bays with fume hood and reactor
Chemspeed / Mettler-Toledo integration
Same-day HPLC and NMR turnaround for R&D samples
Every senior chemist certified
Recent engagement
Client wanted to remove a controlled reagent from an existing route. R&D group delivered a biocatalytic alternative in 12 weeks with equivalent yield.
A ten-page PDF written by our subject-matter lead for this capability. Delivered by email within one business day, always signed by a director.
Full-service contract development and manufacturing under one QA framework.
cGMP API and intermediates production at pilot and commercial scale.
Method development to ICH Q2(R2) validation, plus QC release testing and stability studies.
8-14 week engagements that produce 2-3 viable synthetic routes with scorecards.
Site-to-site and stage-to-stage transfers with signed transfer protocols.
Book a call with the R&D and innovation lead — no gatekeeping, no BD filter.
Chat with us